Insider Trading April 1, 2026

Japan Post Reduces Aflac Holding with $1.59 Million Sale

10% owner disposes of 14,700 shares while retaining a majority stake; Aflac's Q4 2025 showed mixed financial results

By Priya Menon AFL
Japan Post Reduces Aflac Holding with $1.59 Million Sale
AFL

Japan Post Holdings Co., Ltd., which holds roughly ten percent of Aflac Inc., sold 14,700 Aflac shares on March 30, 2026, for about $1.59 million. The shares were sold through an indirect trust structure; the company remains a substantial shareholder. Separately, Aflac reported fourth-quarter 2025 results that missed EPS expectations but topped revenue forecasts, and Mizuho adjusted its price target modestly higher while keeping an Underperform rating.

Key Points

  • Japan Post Holdings sold 14,700 Aflac shares on March 30, 2026, for about $1.59 million - Financials and markets
  • Sale executed via J&A Alliance Holdings Corporation as trustee for the J&A Alliance Trust - Corporate ownership structures
  • Aflac's Q4 2025 EPS missed expectations while revenue exceeded forecasts; Mizuho raised its price target to $107 but kept an Underperform rating - Insurance and financial services

Overview

Japan Post Holdings Co., Ltd. executed a sale of 14,700 shares of common stock in Aflac Inc. (NYSE: AFL) on March 30, 2026, according to a Form 4 filed with the U.S. Securities and Exchange Commission. The transactions generated total proceeds of approximately $1.59 million, with execution prices ranging from $107.07 to $108.89 per share.

Holding structure and remaining stake

The filing specifies that the Aflac shares were held indirectly through J&A Alliance Holdings Corporation, acting as trustee of the J&A Alliance Trust. Japan Post is identified in the filing as the sole settlor and sole beneficiary of that trust. After completing the sale, Japan Post Holdings continues to indirectly own 51,974,500 shares of Aflac.

Market context and valuation note

At the time of the report, Aflac's common stock was trading at $109.36. An InvestingPro analysis cited in the report indicates that the shares are assessed as slightly overvalued relative to InvestingPro's Fair Value estimate.

Recent financials for Aflac

In related corporate disclosures, Aflac released fourth-quarter 2025 financial results showing a divergence between earnings and revenue versus expectations. The company's earnings per share (EPS) for the quarter were $1.57, falling short of the consensus forecast of $1.70 - a downside surprise of 7.65 percent. Revenue for the same period came in at $4.87 billion, above the forecast of $4.28 billion, representing an upside surprise of 13.79 percent.

Analyst update

Mizuho revised its price target on Aflac's stock to $107 from $104, while keeping an Underperform rating. The firm characterized the change as a valuation roll-forward; its maintained rating reflects an anticipated negative return of 6 percent for the stock under its current view.


Context and limits of the record

The Form 4 filing provides the transactional details and the trust arrangement through which Japan Post holds its Aflac shares. The SEC filing and the company financials cited above are the factual bases for the reported sale, remaining stake, and the recent earnings and revenue figures. The information presented here does not attempt to explain motives for the sale beyond what the filing records, nor does it extrapolate future share-price movements.

Risks

  • Insider selling could be interpreted variably by market participants, potentially affecting investor sentiment in the insurance sector - Insurance and equity markets
  • Aflac reported an EPS shortfall for Q4 2025, which may raise near-term performance uncertainty for earnings-driven strategies - Financials and equity analysts
  • Analyst maintained Underperform rating despite a modest price-target increase, indicating continued downside risk in the stock under that assessment - Investment research and valuations

More from Insider Trading

Saba Capital Trims Stake in BlackRock ESG Trust, Selling 262,345 ECAT Shares Apr 1, 2026 Oil States director sells $493k in stake as company posts mixed quarterly results and leadership change Apr 1, 2026 Harvard Bioscience CFO Buys $25,000 of Stock as Company Outlines 2026 Plan Apr 1, 2026 Tonix CEO Makes Notable Purchase as Company Advances Clinical Programs Apr 1, 2026 Rex American Resources CFO Disposes $227K in Shares as Stock Trades Near Yearly High Apr 1, 2026